The rise of Fixed-Dose Combinations (FDCs): What it means for pharma players

Sun Pharma launches FEXUCLUE (Fexuprazan) in India for treatment of Erosive Esophagitis

Prasinezumab hints PD progression delay as assessed by time-to-event: GlobalData